Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
GlaxoSmithKline |
---|---|
Information provided by: | GlaxoSmithKline |
ClinicalTrials.gov Identifier: | NCT00675064 |
This study will examine safety of single doses of GSK369796 in healthy subjects, along with some test to examine how quickly GSK369796 gets in your blood, and how long it takes your body to get rid of it.
Condition | Intervention |
---|---|
Healthy Subjects |
Drug: GSK369796 |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses of GSK369796 in Healthy Subjects |
Ages Eligible for Study: | 18 Years to 40 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
To be eligible, female subjects must have a negative pregnancy test (i.e. serum bhCG test) and be of:
Exclusion Criteria:
Responsible Party: | GSK ( Study Director ) |
Study ID Numbers: | ISO105774 |
Study First Received: | April 22, 2008 |
Last Updated: | October 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00675064 History of Changes |
Health Authority: | United Kingdom: Medicines and Healthcare Products Regulatory Agency |
Healthy volunteers, single ascending dose, pharmacokinetics, safety |
Healthy |